Welspun Corp (532144) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
8 Jul, 2026Executive summary
Achieved record quarterly EBITDA of INR 560 crore with margins at 16% and PAT at INR 350 crore, maintaining a net cash position of INR 600 crore.
Consolidated order book stands at INR 19,000 crore, providing strong visibility for future quarters in India and the US.
Expanded product portfolio with Sintex pipes, targeting a 5% market share of an INR 85,000 crore TAM by FY30, and focus on premium/value-added segments.
Robust demand outlook across India, US, and Saudi Arabia, with significant investments in new plants and capacity expansions.
Unaudited consolidated and standalone financial results for the quarter ended June 30, 2025, were approved by the Board on July 29, 2025.
Financial highlights
Consolidated revenue from operations for Q1 FY26 was ₹3,551.49 crore, up from ₹3,137.23 crore in Q1 FY25.
EBITDA margin improved to 16.21% in Q1 FY26 from 13.84% in Q1 FY25; EBITDA reached an all-time high of INR 560 crore.
Net profit for Q1 FY26 stood at ₹349.16 crore, with annualized ROCE at 24%.
Net cash position of INR 600 crore and net debt/EBITDA at (0.3); net debt/equity at (0.08).
Capex of ~₹450 crore spent in Q1FY26.
Outlook and guidance
Confident in meeting or exceeding FY26 guidance, supported by strong order book and diversified business segments.
FY26 revenue guidance at ₹17,500 crore, with Q1FY26 progress at ₹3,552 crore; EBITDA guidance for FY26 is ₹2,200 crore.
CapEx of INR 1,300 crore planned over the next 2-3 years, mainly for OPVC business, with 40-45% expected in the current year.
ROCE guidance above 20%, with Q1FY26 annualized at 24%.
Net debt/EBITDA expected to remain below 1.0.
Latest events from Welspun Corp
- Record EBITDA and profit, strong order book, and major gain from EPIC stake sale.532144
Q1 26/27 - FY26 revenue reached nearly ₹17,000 crore, with strong growth and robust FY27 guidance.532144
Q4 25/26 - Record revenue, EBITDA, and order book drive strong growth and top-tier ESG performance.532144
Q3 25/26 - Targeting 15-20% revenue CAGR and top-tier ESG, with global expansion and innovation focus.532144
Investor Day 2025 Presentation - Record order book, highest-ever EBITDA, and global expansion drive strong growth outlook.532144
Q2 25/26 - Q2 FY25 saw strong profit and major project approvals, driving future growth.532144
Q2 24/25 - Q3 FY25 delivered strong growth, robust order book, and major gain from EPIC share sale.532144
Q3 24/25 - FY26 guidance targets 25% revenue and 18% EBITDA growth, backed by strong order book.532144
Q4 24/25